Interpace Biosciences, Inc. (IDXG)
OTCMKTS
· Delayed Price · Currency is USD
0.8000
+0.0200 (2.56%)
May 28, 2025, 2:12 PM EDT
Interpace Biosciences Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Net Income | 7.64 | 6.7 | 1.95 | -21.96 | -14.94 | -26.45 | Upgrade
|
| Depreciation & Amortization | 0.78 | 0.75 | 1.6 | 3.5 | 5.37 | 5.5 | Upgrade
|
| Other Amortization | 0.01 | - | 0.04 | 0.06 | 0.12 | - | Upgrade
|
| Loss (Gain) From Sale of Assets | - | - | - | -0.07 | 0.06 | - | Upgrade
|
| Asset Writedown & Restructuring Costs | - | - | - | 12.4 | - | 0.04 | Upgrade
|
| Stock-Based Compensation | 0.23 | 0.29 | 0.63 | 1.3 | 1.37 | 2.24 | Upgrade
|
| Provision & Write-off of Bad Debts | 0.1 | - | - | - | -0.14 | 0.59 | Upgrade
|
| Other Operating Activities | 0.44 | 0.58 | 0.8 | 1.07 | 0.57 | -1.12 | Upgrade
|
| Change in Accounts Receivable | -3.74 | -3.47 | 0.23 | -0.13 | 2.15 | 1.73 | Upgrade
|
| Change in Accounts Payable | 0.36 | 0.12 | 0.49 | -0.74 | -1.82 | -0.2 | Upgrade
|
| Change in Other Net Operating Assets | 0.15 | -0.33 | -1.95 | -3.12 | -1.46 | 3.7 | Upgrade
|
| Operating Cash Flow | 5.94 | 4.65 | 3.79 | -7.69 | -8.72 | -13.98 | Upgrade
|
| Operating Cash Flow Growth | 128.60% | 22.62% | - | - | - | - | Upgrade
|
| Capital Expenditures | -0.85 | -0.88 | -0.47 | -0.32 | -0.35 | -1.58 | Upgrade
|
| Sale of Property, Plant & Equipment | - | - | - | - | 0.04 | - | Upgrade
|
| Other Investing Activities | - | - | 0.38 | 6.53 | - | - | Upgrade
|
| Investing Cash Flow | -0.85 | -0.88 | -0.09 | 6.21 | -0.32 | -1.58 | Upgrade
|
| Short-Term Debt Issued | - | - | - | 2 | 7.5 | - | Upgrade
|
| Long-Term Debt Issued | - | - | - | 1 | 9.5 | - | Upgrade
|
| Total Debt Issued | - | - | - | 3 | 17 | - | Upgrade
|
| Short-Term Debt Repaid | - | - | - | - | -7.92 | - | Upgrade
|
| Long-Term Debt Repaid | - | -5.6 | -2.5 | - | - | -3 | Upgrade
|
| Total Debt Repaid | -6.5 | -5.6 | -2.5 | - | -7.92 | -3 | Upgrade
|
| Net Debt Issued (Repaid) | -6.5 | -5.6 | -2.5 | 3 | 9.08 | -3 | Upgrade
|
| Issuance of Common Stock | - | - | - | 0.11 | 0.34 | 0.43 | Upgrade
|
| Repurchase of Common Stock | -0.05 | -0.05 | -0.03 | -0.11 | - | -0.05 | Upgrade
|
| Other Financing Activities | -0.16 | -0.16 | -2.5 | - | -0.44 | - | Upgrade
|
| Financing Cash Flow | -6.71 | -5.81 | -5.03 | 3 | 8.98 | 16.61 | Upgrade
|
| Net Cash Flow | -1.62 | -2.04 | -1.33 | 1.51 | -0.06 | 1.05 | Upgrade
|
| Free Cash Flow | 5.09 | 3.77 | 3.32 | -8.01 | -9.07 | -15.55 | Upgrade
|
| Free Cash Flow Growth | 135.15% | 13.59% | - | - | - | - | Upgrade
|
| Free Cash Flow Margin | 10.55% | 8.03% | 8.29% | -25.17% | -27.40% | -48.01% | Upgrade
|
| Free Cash Flow Per Share | 0.24 | 0.24 | 0.76 | -1.89 | -2.19 | -3.86 | Upgrade
|
| Cash Interest Paid | 0.63 | 0.63 | 1.09 | 0.97 | 0.42 | 0.06 | Upgrade
|
| Cash Income Tax Paid | 0.27 | 0.27 | 0.27 | 0.25 | 0.37 | 0.22 | Upgrade
|
| Levered Free Cash Flow | -4.08 | 1.41 | -1.19 | -0.03 | 1.78 | -5.08 | Upgrade
|
| Unlevered Free Cash Flow | -3.76 | 1.82 | -0.6 | 0.54 | 2.31 | -4.74 | Upgrade
|
| Change in Net Working Capital | 9.44 | 3.41 | 4.84 | 1.55 | 0.25 | -4.08 | Upgrade
|
Updated Nov 8, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.